These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8446807)

  • 1. A comprehensive algorithm for determining whether a run-in strategy will be a cost-effective design modification in a randomized clinical trial.
    Schechtman KB; Gordon ME
    Stat Med; 1993 Jan; 12(2):111-28. PubMed ID: 8446807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a run-in to enhance compliance.
    Lang JM
    Stat Med; 1990; 9(1-2):87-93; discussion 93-5. PubMed ID: 2345841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of a run-in period in a drug trial during pregnancy.
    Blackwelder WC; Hastings BK; Lee ML; Deloria MA
    Control Clin Trials; 1990 Jun; 11(3):187-98. PubMed ID: 2163814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the effect of the run-in on the power of the Physicians' Health Study.
    Lang JM; Buring JE; Rosner B; Cook N; Hennekens CH
    Stat Med; 1991 Oct; 10(10):1585-93. PubMed ID: 1947514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study duration.
    Backhouse ME
    Pharmacoeconomics; 2002; 20(15):1061-77. PubMed ID: 12456201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subject recruitment, retention, and compliance in clinical trials in periodontics.
    Milgrom PM; Hujoel PP; Weinstein P; Holborow DW
    Ann Periodontol; 1997 Mar; 2(1):64-74. PubMed ID: 9151543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The run-in period in clinical trials. The effect of misclassification on efficiency.
    Brittain E; Wittes J
    Control Clin Trials; 1990 Oct; 11(5):327-38. PubMed ID: 2289394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial.
    Dew A; Khan S; Babinski C; Michel N; Heffernan M; Stephan S; Jordan N; Jovanovic B; Carney P; Bergan R
    Clin Trials; 2013 Apr; 10(2):292-9. PubMed ID: 23321266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and cost-effectiveness of an automated screening algorithm in an inpatient clinical trial.
    Beauharnais CC; Larkin ME; Zai AH; Boykin EC; Luttrell J; Wexler DJ
    Clin Trials; 2012 Apr; 9(2):198-203. PubMed ID: 22308560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing a cost-effective clinical trial.
    Hornberger JC; Brown BW; Halpern J
    Stat Med; 1995 Oct; 14(20):2249-59. PubMed ID: 8552901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional cash transfers to retain rural Kenyan women in the continuum of care during pregnancy, birth and the postnatal period: protocol for a cluster randomized controlled trial.
    Ochieng CA; Haghparast-Bidgoli H; Batura N; Odhiambo A; Shannon G; Copas A; Palmer T; Dickin S; Noel S; Fielding M; Onyango S; Odera S; Eleveld A; Mwaki A; Vanhuyse F; Skordis J
    Trials; 2019 Mar; 20(1):152. PubMed ID: 30823886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Power and sample size calculations for stochastic cost-effectiveness analysis.
    Briggs AH; Gray AM
    Med Decis Making; 1998; 18(2 Suppl):S81-92. PubMed ID: 9566469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of health research study participant recruitment strategies: a systematic review.
    Huynh L; Johns B; Liu SH; Vedula SS; Li T; Puhan MA
    Clin Trials; 2014 Oct; 11(5):576-83. PubMed ID: 24980278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit and extended cost-effectiveness analysis of a comprehensive adolescent pregnancy prevention program in Zambia: study protocol for a cluster randomized controlled trial.
    Mori AT; Kampata L; Musonda P; Johansson KA; Robberstad B; Sandøy I
    Trials; 2017 Dec; 18(1):604. PubMed ID: 29258591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability, effect size, and responsiveness of health status measures in the design of randomized and cluster-randomized trials.
    Diehr P; Chen L; Patrick D; Feng Z; Yasui Y
    Contemp Clin Trials; 2005 Feb; 26(1):45-58. PubMed ID: 15837452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.